Saul Schaefer, M.D.

Saul Schaefer, M.D.



Cardiovascular Medicine

Internal Medicine


Internal Medicine


  • Chief of Cardiology at VA Medical Center in Sacramento
  • Professor
To see if Saul Schaefer is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Lawrence J. Ellison Ambulatory Care Center

4860 Y St., Suite 0200
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Physician Referrals: 916-916--734-5678

Clinical Interests

Saul Schaefer focuses his clinical research on the efficacy of contrast-enhanced cardiac MRI to define abnormal perfusion in patients with ischemic heart disease and MRI of coronary blood flow and anatomy with intravenous adenosine. Schaefer's laboratory studies involve regulation of myocardial metabolism and ion transport during low flow and total ischemia. He also is researching use of perfused heart models of ischemic preconditioning and hibernating myocardium, coupled with nuclear magnetic resonance spectroscopy (MRS) and biochemical assays, to define adaptive mechanisms to ischemia.


Cardiovascular Medicine

Center/Program Affiliation

Cardiovascular Services


M.D., UC Davis School of Medicine, Sacramento, California, 1981


University of California, San Francisco, San Francisco, California, 1981-84


University of Texas Southwestern Medical Center, Dallas, Texas, 1984-87

Board Certifications

American Board of Internal Medicine, 1984

American Board of Internal Medicine, Cardiovascular Disease, 1987

Professional Memberships

American College of Cardiology

American Federation of Clinical Research

American Heart Association

American Society of Echocardiography

Society of Magnetic Resonance in Medicine

Select Recent Publications

Phillips W, Schaefer S. LDL= 5: Virtues and Dangers of Multidrug Therapy of Low-Density Lipoprotein Cholesterol. Journal of Preventative Cardiology, 2010;13: 71.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators. [Saul Schaefer member of the Dabigatran Study Group]. Dabigatran versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 2009;361(12): 1139-51.

Konia M, Schaefer S, H Liu. Nuclear factor-kB inhibition provides additional protection against ischemia reperfusion injury in sevoflurane preconditioning. European Journal of Anesthesiology, 2009;26: 496-503.

Lopez JE, Yeo KK, Caputo G, Buonocore M, Schaefer S. Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 2009;11(1): 46. Publications and Contributions to Jointly Authored Works 7

Lu X, Liu H, Wang, L, Schaefer S. Activation of NF-kB is a critical element in the anti-apoptotic effect of anesthetic preconditioning. American

Tamse C, Lu X, Mortel E, Cabrales E, Feng W, S Schaefer. The Peripheral Benzodiazepine Receptor Modulates Ca2 Transport through the VDAC in Rat Heart Mitochondria. Journal of Clinical and Basic Cardiology, 2008;11: 24-29.

Southard J, Baker L, S Schaefer. In Search of the False-Negative ETT -Evidence-Based Use of Exercise Echocardiography. Clinical Cardiology, 2007;30.